09/15/23 2:45 PMNYSE : ROSS acquisitionlow floatRoss Acquisition Corp II Announces Shareholder Approval of Extension of Deadline to Complete a Business CombinationRoss Acquisition Corp II (NYSE:ROSS) (the “Company”) announced today that its shareholders approved amendments to the Company’s Amended and Restated Memorandum and Articles of Association to, amongst other things, extend the date by which theRHEA-AIneutral
09/01/23 6:00 AMNYSE : ROSS acquisitionlow floatRoss Acquisition Corp II Announces Meeting for Shareholders to Extend Date for Business CombinationRoss Acquisition Corp II (NYSE:ROSS) (the “Company”) announced that on August 31, 2023 it filed a definitive proxy statement (the “Definitive Proxy Statement”) for the solicitation of proxies in connection with an extraordinary general meetingRHEA-AInegative
08/28/23 4:31 PMNYSE : ROSS acquisitionlow floatRoss Acquisition Corp II Receives NYSE Notice Regarding Delayed Form 10-Q FilingRoss Acquisition Corp II (NYSE:ROSS) (the “Company”) announced today that it received a notice (the “Notice”) on August 22, 2023 from the NYSE Regulation staff of the New York Stock Exchange (the “NYSE”) stating that the Company is not inRHEA-AIneutral
01/18/23 6:50 AMNYSE : ROSS, WS acquisitionlow floatAPRINOIA Therapeutics and ROSS Acquisition Corp II Announce Business Combination Agreement to Create Publicly Listed Company Focused on Neurodegenerative DiseasesAPRINOIA Therapeutics Inc., a clinical-stage biotechnology company focused on neurodegenerative diseases such as Alzheimer's Disease and Progressive Supranuclear Palsy, and Ross Acquisition Corp II, a special purpose acquisition company founded by former Commerce Secretary Wilbur Ross, today...RHEA-AIneutral
05/27/21 6:48 PMNYSE : ROSS acquisitionlow floatRoss Acquisition Corp II Receives Expected NYSE Notice Regarding Delayed Form 10-Q FilingRoss Acquisition Corp II (NYSE: ROSS) (the "Company") today announced that it has regained compliance with Section 802.01E of the New York Stock Exchange ("NYSE") Listed Company Manual (the "Rule") after filing its Quarterly Report on Form 10-Q for theRHEA-AIneutral
